mainstream reporters and editors and publishers are well aware that telling the truth and continuing to pound on it would undermine a basic institution of society. . .
erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the .